Christine C Jacobson, MD
Dermatology · San Bruno
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 4
- 1 carrier
- Office
- 1
Offices
1 location · Permanente Medical Group Inc · 10,928 clinicians in this group
Plans that list them
4 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Jacobson’s office at (650) 742-7226 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Kaiser Permanente Dual Complete North P2 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Dual Complete North P23 (HMO D-SNP) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Basic Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
| Kaiser Permanente Sr Adv Enhanced Santa Clara (HMO) | Kaiser Permanente | Listed | Sep 1, 2026 |
California Medical Board record
Licence A92376 · Current
Licensed to practise in California · since 2005 · expires 2027-08-31 · Stanford University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Original Medicare doctor bills
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
| Skin biopsy | 1-10 | None |
Year by year
| 2016 | 11 | 17 | 67 | 1.86 | $3,564 | $742 |
| 2013 | 113 | 267 | 74 | 1.02 | $66,204 | $11,496 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2013: 7 services
| Destruction of precancer skin growth, 1 growth | 51 | $2,057 | $38 |
| Biopsy of single growth of skin and/or tissue | 21 | $1,678 | $80 |
| Short return visit (20+ min) | 57 | $1,387 | $23 |
| Destruction of skin growth, 1-14 growths | 17 | $985 | $52 |
| Short return visit | 12 | $242 | $20 |
| Destruction of precancer skin growth, 2-14 growths | 40 | $198 | $5 |
| New patient visit (15+ min) | 11 | $163 | $15 |
Drugs they prescribed that Part D paid
$355,233
Pharmacies billed $355,233 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 706) in 2024. At or below the middle of the specialty; the typical dermatology clinician is at 0%.
584 generic and 122 brand-name prescriptions · $355,233 in drug cost · 28 antibiotic prescriptions to 20 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Cosentyx Sensoready (2 Pens) | 21 | $119,002 | $5,667 |
| Amjevita(Cf) | 38 | $56,393 | $1,484 |
| Tacrolimus | 44 | $3,601 | $82 |
| Pimecrolimus | 18 | $2,304 | $128 |
| Clobetasol Propionate | 67 | $2,111 | $32 |
See all 19 drugs
| Cosentyx Sensoready (2 Pens) | 21 | $119,002 | $5,667 |
| Amjevita(Cf) | 38 | $56,393 | $1,484 |
| Tacrolimus | 44 | $3,601 | $82 |
| Pimecrolimus | 18 | $2,304 | $128 |
| Clobetasol Propionate | 67 | $2,111 | $32 |
| Halobetasol Propionate | 15 | $1,596 | $106 |
| Triamcinolone Acetonide | 90 | $1,578 | $18 |
| Betamethasone Diprop Augmented | 43 | $1,522 | $35 |
| Fluocinonide | 49 | $1,180 | $24 |
| Metronidazole | 30 | $1,146 | $38 |
| Dapsone | 11 | $884 | $80 |
| Hydrocortisone | 37 | $703 | $19 |
| Doxepin | 26 | $659 | $25 |
| Fluorouracil | 12 | $487 | $41 |
| Retin-A | 19 | $435 | $23 |
| Doxycycline Hyclate | 19 | $384 | $20 |
| Doxycycline Monohydrate | 16 | $347 | $22 |
| Mupirocin | 12 | $161 | $13 |
| Minoxidil | 11 | $100 | $9 |
Year by year
| 2024 | 706 | 240 | 0% (0) | 17% | $355,233 |
| 2023 | 699 | 237 | 0% (0) | 17% | $241,238 |
| 2022 | 717 | 225 | 0% (0) | 14% | $161,247 |
| 2021 | 528 | 171 | 0% (0) | 15% | $101,679 |
| 2020 | 460 | 167 | 0% (0) | 15% | $92,357 |
| 2019 | 528 | 196 | 0% (0) | 15% | $78,609 |
| 2018 | 425 | 163 | 0% (0) | 21% | $55,138 |
| 2017 | 481 | 159 | 0% (0) | 27% | $99,333 |
| 2016 | 400 | 159 | 0% (0) | 27% | $75,831 |
| 2015 | 314 | 130 | 0% (0) | 14% | $29,465 |
| 2014 | 335 | 140 | 0% (0) | 13% | $22,815 |
| 2013 | 322 | 160 | 0% (0) | None | $36,342 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 18 drugs
| Amjevita(Cf) | 37 | $76,367 | $2,064 |
| Humira | 15 | $64,029 | $4,269 |
| Tacrolimus | 37 | $3,674 | $99 |
| Clobetasol Propionate | 80 | $2,583 | $32 |
| Acitretin | 12 | $2,063 | $172 |
| Betamethasone Diprop Augmented | 40 | $1,919 | $48 |
| Pimecrolimus | 11 | $1,879 | $171 |
| Triamcinolone Acetonide | 70 | $1,247 | $18 |
| Fluocinonide | 38 | $1,109 | $29 |
| Metronidazole | 22 | $910 | $41 |
| Doxepin | 31 | $765 | $25 |
| Retin-A | 23 | $671 | $29 |
| Doxycycline Hyclate | 28 | $603 | $22 |
| Fluorouracil | 12 | $501 | $42 |
| Hydrocortisone | 31 | $459 | $15 |
| Doxycycline Monohydrate | 12 | $407 | $34 |
| Mupirocin | 12 | $150 | $13 |
| Methotrexate | 15 | $127 | $8 |
2022: 17 drugs
| Humira | 11 | $53,583 | $4,871 |
| Cosentyx Pen (2 Pens) | 12 | $38,257 | $3,188 |
| Tacrolimus | 47 | $5,822 | $124 |
| Clobetasol Propionate | 100 | $3,649 | $36 |
| Fluocinonide | 57 | $2,396 | $42 |
| Betamethasone Diprop Augmented | 36 | $2,054 | $57 |
| Betamethasone Valerate | 20 | $1,779 | $89 |
| Metronidazole | 34 | $1,717 | $51 |
| Retin-A | 36 | $1,573 | $44 |
| Fluorouracil | 18 | $1,013 | $56 |
| Triamcinolone Acetonide | 59 | $987 | $17 |
| Doxycycline Hyclate | 27 | $768 | $28 |
| Doxycycline Monohydrate | 25 | $721 | $29 |
| Doxepin | 22 | $576 | $26 |
| Hydrocortisone | 37 | $547 | $15 |
| Methotrexate | 18 | $154 | $9 |
| Mupirocin | 11 | $142 | $13 |
2021: 15 drugs
| Cosentyx Pen (2 Pens) | 11 | $21,773 | $1,979 |
| Betamethasone Diprop Augmented | 45 | $3,908 | $87 |
| Clobetasol Propionate | 54 | $3,346 | $62 |
| Tacrolimus | 32 | $3,308 | $103 |
| Fluocinonide | 49 | $2,802 | $57 |
| Metronidazole | 28 | $1,711 | $61 |
| Vectical | 11 | $1,628 | $148 |
| Fluocinolone Acetonide | 12 | $866 | $72 |
| Triamcinolone Acetonide | 46 | $836 | $18 |
| Doxycycline Hyclate | 30 | $803 | $27 |
| Doxycycline Monohydrate | 12 | $463 | $39 |
| Hydrocortisone | 20 | $389 | $19 |
| Methotrexate | 26 | $247 | $9 |
| Ketoconazole | 11 | $228 | $21 |
| Mupirocin | 13 | $168 | $13 |
2020: 15 drugs
| Cosentyx Pen (2 Pens) | 11 | $20,381 | $1,853 |
| Clobetasol Propionate | 47 | $3,270 | $70 |
| Fluocinonide | 34 | $2,921 | $86 |
| Betamethasone Diprop Augmented | 38 | $2,487 | $65 |
| Tacrolimus | 20 | $2,310 | $115 |
| Vectical | 14 | $1,945 | $139 |
| Metronidazole | 19 | $1,062 | $56 |
| Triamcinolone Acetonide | 44 | $889 | $20 |
| Doxycycline Hyclate | 31 | $733 | $24 |
| Fluorouracil | 11 | $698 | $63 |
| Doxycycline Monohydrate | 13 | $583 | $45 |
| Mometasone Furoate | 11 | $393 | $36 |
| Hydrocortisone | 21 | $356 | $17 |
| Hydroxychloroquine Sulfate | 11 | $233 | $21 |
| Methotrexate | 17 | $148 | $9 |
2019: 15 drugs
| Cosentyx Pen (2 Pens) | 12 | $23,493 | $1,958 |
| Clobetasol Propionate | 64 | $6,211 | $97 |
| Fluocinonide | 55 | $4,428 | $81 |
| Betamethasone Diprop Augmented | 59 | $3,515 | $60 |
| Tacrolimus | 19 | $2,281 | $120 |
| Triamcinolone Acetonide | 59 | $1,759 | $30 |
| Mycophenolate Mofetil | 14 | $1,261 | $90 |
| Doxycycline Hyclate | 28 | $707 | $25 |
| Metronidazole | 12 | $643 | $54 |
| Doxycycline Monohydrate | 15 | $568 | $38 |
| Hydrocortisone | 27 | $516 | $19 |
| Ketoconazole | 15 | $349 | $23 |
| Prednisone | 12 | $272 | $23 |
| Methotrexate | 21 | $208 | $10 |
| Mupirocin | 12 | $163 | $14 |
2018: 9 drugs
| Clobetasol Propionate | 47 | $10,769 | $229 |
| Fluocinonide | 37 | $3,707 | $100 |
| Betamethasone Diprop Augmented | 39 | $3,613 | $93 |
| Tacrolimus | 11 | $2,396 | $218 |
| Triamcinolone Acetonide | 51 | $2,043 | $40 |
| Doxycycline Hyclate | 21 | $559 | $27 |
| Methotrexate | 25 | $490 | $20 |
| Doxepin | 20 | $451 | $23 |
| Hydrocortisone | 17 | $200 | $12 |
2017: 15 drugs
| Clobetasol Propionate | 43 | $11,200 | $260 |
| Betamethasone Dipropionate | 44 | $4,866 | $111 |
| Fluocinonide | 45 | $4,596 | $102 |
| Triamcinolone Acetonide | 47 | $3,372 | $72 |
| Tacrolimus | 13 | $2,856 | $220 |
| Vectical | 11 | $1,264 | $115 |
| Betamethasone Valerate | 14 | $746 | $53 |
| Doxycycline Monohydrate | 12 | $532 | $44 |
| Methotrexate | 43 | $514 | $12 |
| Hydroxychloroquine Sulfate | 13 | $508 | $39 |
| Doxycycline Hyclate | 15 | $445 | $30 |
| Hydrocortisone | 23 | $390 | $17 |
| Mometasone Furoate | 12 | $292 | $24 |
| Mupirocin | 12 | $181 | $15 |
| Hydroxyzine | 11 | $113 | $10 |
2016: 12 drugs
| Clobetasol Propionate | 32 | $9,770 | $305 |
| Triamcinolone Acetonide | 60 | $4,461 | $74 |
| Betamethasone Dipropionate | 26 | $3,476 | $134 |
| Tacrolimus | 14 | $3,199 | $229 |
| Fluocinonide | 26 | $2,983 | $115 |
| Metronidazole | 13 | $1,350 | $104 |
| Fluorouracil | 11 | $1,252 | $114 |
| Clindamycin Phosphate | 11 | $1,056 | $96 |
| Doxycycline Hyclate | 21 | $906 | $43 |
| Hydrocortisone | 26 | $581 | $22 |
| Methotrexate | 23 | $303 | $13 |
| Cephalexin | 14 | $254 | $18 |
2015: 7 drugs
| Clobetasol Propionate | 39 | $9,088 | $233 |
| Triamcinolone Acetonide | 42 | $2,583 | $61 |
| Betamethasone Dipropionate | 23 | $2,256 | $98 |
| Fluocinonide | 21 | $2,043 | $97 |
| Metronidazole | 16 | $1,385 | $87 |
| Doxycycline Hyclate | 18 | $1,080 | $60 |
| Hydrocortisone | 21 | $436 | $21 |
2014: 7 drugs
| Triamcinolone Acetonide | 52 | $3,259 | $63 |
| Fluocinonide | 29 | $2,165 | $75 |
| Betamethasone Dipropionate | 24 | $1,810 | $75 |
| Clobetasol Propionate | 27 | $1,579 | $58 |
| Fluocinonide-E | 13 | $690 | $53 |
| Hydrocortisone | 33 | $678 | $21 |
| Cephalexin | 12 | $185 | $15 |
2013: 9 drugs
| Protopic | 13 | $3,029 | $233 |
| Metronidazole | 13 | $1,750 | $135 |
| Triamcinolone Acetonide | 46 | $1,722 | $37 |
| Tretinoin | 16 | $1,154 | $72 |
| Desonide | 16 | $887 | $55 |
| Doxycycline Hyclate | 11 | $770 | $70 |
| Clobetasol Propionate | 21 | $577 | $27 |
| Ketoconazole | 18 | $374 | $21 |
| Cephalexin | 13 | $212 | $16 |
Money from drug and device companies
$75 in 2023
A payment is not proof that care is biased.
| Pfizer | None | $75 | 1 payment
|
See the published payment
| Pfizer | Meals · 2023-01-14 | None | $75 |
Professional record
- NPI
- 1376756031
- Licence
- CA A92376California A92376: Current · expires 2027-08-31
- Trained
- Stanford University School of Medicine, 2004
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207N00000X (207N00000X)
- Mailing address
- 1445 Castro St, San Francisco, CA, 94114
- NPI first listed
- 2007-05-08
- NPI last updated
- 2021-12-22
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.